Philadelphia-based information technology and information services company HealthVerity has secured $25 million in Series C funding, according to company database Crunchbase, topping the city’s recent funding headlines. The cash infusion was announced April 3 and led by Foresite Capital.
According to its Crunchbase profile, "HealthVerity is a leading provider of technologies and software tools that enable health-care providers, such as pharmaceutical manufacturers, hospitals and payers, to discover, license and integrate patient data from a wide range of traditional and emerging data sources to build the optimal patient data set."
The five-year-old company has raised two previous funding rounds, including a $10 million Series B round in 2017.
The round brings total funding raised by Philadelphia companies in health care over the past month to $45 million. The local health-care industry has seen 30 funding rounds over the past year, raking in a total of $207 million in venture funding.
In other local funding news, therapeutics company Scout Bio announced a $20 million Series B funding round on April 10, led by RiverVest.
According to Crunchbase, "Scout Bio, (is) a Philadelphia, PA-based biotechnology company focused on innovating pet medicine by delivering a pipeline of one-time therapeutics for major chronic pet health conditions."
The company also raised a $9.2 million Series A round in 2018.